Table 2.
Medication Nonadherence and Physician–patient Dialogue (All Items Refer to the Last 12 Months)
| Total | 3+ Chronic conditions (35.2%)* | |
|---|---|---|
| Rates of medication nonadherence (%) | ||
| Any nonadherence†- | 40.1 | 52.1 |
| Any cost-related nonadherence | 26.3 | 34.9 |
| Not filling prescription because of cost | 18.3 | 24.9 |
| Skipping doses to make prescription last longer | 15.8 | 21.8 |
| Taking a smaller dose to make prescription last longer | 12.4 | 18.5 |
| Any nonadherence not related to cost | 28.2 | 37.4 |
| Nonadherence because of experiences‡ | 24.4 | 33.8 |
| Nonadherence because of self-assessed need‡ | 14.5 | 18.8 |
| Physician–patient dialogue (% yes) | ||
| Did your doctor talk with you about all your medicines? | 68.2 | 75.8 |
| Did you talk with any of your doctors about prescription medicine costs? | 30.9 | 41.3 |
| Did you talk with any of your doctors about changing a medicine because it was making you feel worse or was not working? | 28.9 | 41.9 |
We applied sampling weights to all results to correct for difference in sampling probabilities across the strata. The total observed sample size was 17,569, of which 5,739 had 3 or more chronic conditions.
*For each row, we examined the trend for 0, 1, 2, and 3 or more chronic conditions, and for each the trend was significant, P < .001. For simplicity, we present only the rates for 3 or more conditions.
†“Any cost-related nonadherence” refers to beneficiaries who reported nonadherence on any of the cost or noncost items (items 1–3 and 5–8 in the Appendix).
‡These rows each summarize 2 survey items.